无标定检测市场 - 全球产业规模、份额、趋势、机会及预测（按产品、技术、应用、地区和竞争格局划分，2021-2031年）

全球无标定侦测 (LFD) 市场预计将从 2025 年的 19.1 亿美元成长到 2031 年的 29.1 亿美元，复合年增长率为 7.21%。

无标定检测 (LFD) 是一种生物分析技术，它不依赖萤光或放射性标记物，能够即时观察分子相互作用，从而保持分析物的天然状态。这一市场趋势的主要驱动力是製药业日益增长的需求，即提高药物研发效率并减少后期研发失败率。根据欧洲製药工业协会联合会 (EFPIA) 预测，到 2024 年，欧洲以研发为基础的製药业预计将在研发方面投入约 550 亿欧元。这项数据表明，巨大的经济利益正在推动製药业采用 LFD 等高精度分析工具，以优化研究成果并最大化投资回报。

儘管有这些驱动因素，但由于LFD设备需要高昂的初始资本投入，市场仍面临许多障碍，这往往限制了小规模学术实验室和新兴生物技术公司使用该设备。数据分析固有的技术复杂性进一步加剧了这种成本敏感性，因为并非所有研究环境都具备专门的培训。因此，这些财务和营运方面的障碍对这项技术在全球生命科学界的广泛应用构成了重大挑战。

市场驱动因素

医药品研究开发费用的医药品研究开发费用成长是推动无标定检测技术应用的主要因素。面对简化药物研发流程和降低后期失败率的压力，製药公司正积极投资能够提供高精度动力学数据的生物分析工具。主要产业参与者优先考虑缩短先导化合物发现时间并提高结合亲和性测量准确性的技术，这充分体现了上述投资。例如，根据《先导化合物技术》杂誌报道，默克公司在2024年5月公布，其2023年全年研发支出将达到305亿美元，这反映了整个行业投资于药物发现基础设施的趋势，而这些基础设施依赖用于精确分子相互作用分析的专用设备。

同时，对生物製剂和个人化医疗日益增长的关注正在重塑对无标定系统的需求。与小分子不同，诸如单株抗体等复杂生物製剂在用萤光标记物标记后，其结合行为通常会发生改变，因此，在筛检中，无标定分析对于保持分析物的天然结构至关重要。这些大分子疗法的商业性成功正在推动市场需求。普渡大学报告称，截至2024年5月，美国FDA已核准2023年上市的24种生物製药，占新上市疗法的绝大多数。此外，旨在保障研究能力的公共部门措施正在加强全球生态系统。据英国政府称，已于2024年10月设立了5.2亿英镑的生命科学创新製造基金，旨在促进该领域的投资，并创造有利于先进分析技术广泛应用的环境。

市场挑战

无标定侦测 (LFD) 仪器的高昂初始资本投入是其市场扩张的一大障碍。这些先进的分析系统需要大量的前期投资，这往往阻碍了预算有限的小规模学术实验室和新兴生物技术公司采用。与大型製药企业不同，这些小规模的机构难以承担这些成本，只能依赖传统的、成本较低的标记方法。这种价格敏感性实际上排除了很大一部分潜在客户，限制了该技术在生命科学领域的普及，使其主要集中在资金雄厚的机构中。

生物技术领域资金筹措环境的恶化进一步加剧了这一财务障碍。据生物技术创新组织（BIO）称，「2024年第一季，早期药物研发公司的创业投资投资额预计约为24亿美元，反映出新兴企业资金筹措环境较为谨慎。」 由于资金筹措有限，新兴企业被迫优先考虑临床开发支出，而非购买昂贵的资本设备。因此，这些新兴企业购买力的下降直接抑制了对LFD设备的需求，阻碍了整个市场的成长。

市场趋势

人工智慧 (AI) 和机器学习在动力学分析中的应用，从根本上改变了无标定检测领域中复杂结合数据的解读方式。随着生物分析平台产生的资料集日益庞大，人工处理已成为瓶颈，促使人们采用能够即时分解复杂动力学曲线的运算工具。这项数位化转型源自于提高结合亲和性计算精度以及在药物研发早期预测分子行为的需求。产业对此技术变革的投入也反映在近期的资本配置中。根据皮斯托亚联盟 (Pistoia Alliance) 2025 年 9 月发布的《未来实验室调查》，人工智慧仍是 63% 生命科学实验室的重点投资领域，这支持了向数据驱动型分析框架的策略转型，从而提升无标定仪器的效用。

同时，自动化和机器人整合工作流程的兴起，满足了药物筛检领域对高通量和高重复性的需求，从而推动了市场成长。实验室越来越重视能够支持大规模宣传活动连续无人运作的系统，摒弃了容易出现偏差的手动样品处理方式。製造商也积极回应，推出了可无缝整合到机器人生态系统中并最大限度提高设备利用率的先进仪器。例如，赛多利斯公司宣布将于2025年5月推出其Octet R8e系统，并指出该平台采用的新型蒸发控制技术可实现长达16小时的无人实验运作。这项特性显着延长了动力学分析的运行时间，从而满足了现代高通量环境所需的连续分析需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

5. 全球无标定侦测 (LFD) 市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（耗材、设备）
  • 透过技术（质谱法、表面等离子体共振法（SPR）、生物层干涉法、等温滴定量热法、差示扫描量热法等）
  • 依应用领域（结合动力学、结合动态、内源性受体检测、先导化合物确认、先导化合物生成等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美无标定侦测 (LFD) 市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲无标定侦测 (LFD) 市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区无标定检测（LFD）市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲无标定检测 (LFD) 市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲无标定检测 (LFD) 市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球无标定侦测（LFD）市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Ametek Inc
• Corning Incorporated
• Cytiva（Danaher Corporation）
• Horiba Ltd.
• Malvern Panalytical Ltd
• PerkinElmer Inc.
• Shimadzu Corporation
• Thermo Fisher Scientific

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Label-Free Detection (LFD) Market is projected to expand from USD 1.91 Billion in 2025 to USD 2.91 Billion by 2031, reflecting a CAGR of 7.21%. Label-free detection (LFD) refers to bioanalytical methods that facilitate the real-time observation of molecular interactions without relying on fluorescent or radioactive markers, thereby maintaining the analyte's natural state. This market trajectory is primarily supported by the pharmaceutical sector's intensifying need to enhance drug discovery efficiency and reduce late-stage development failures. According to 'EFPIA', in '2024', 'the research-based pharmaceutical industry invested an estimated €55,000 million in R&D in Europe', a statistic that underscores the massive financial stakes driving the adoption of high-fidelity analytical tools like LFD to optimize research outcomes and maximize return on investment.

Despite these drivers, the market faces a significant impediment regarding the high initial capital expenditure required for LFD instrumentation, which often restricts access for smaller academic laboratories and emerging biotechnology firms. This cost sensitivity is compounded by the technical complexity inherent in data analysis, necessitating specialized training that may not be available in all research settings. Consequently, these financial and operational barriers present a substantial challenge to the broader penetration of this technology across the global life sciences community.

Market Driver

Escalating Pharmaceutical R&D Expenditure for Drug Discovery and Development serves as a paramount catalyst for the adoption of label-free detection technologies. As pharmaceutical entities face pressure to streamline drug development pipelines and mitigate late-stage attrition, they are aggressively channeling capital into bioanalytical tools that offer high-fidelity kinetic data. This financial commitment is evident in the strategies of major industry players who prioritize technologies capable of accelerating hit-to-lead times and improving the accuracy of binding affinity measurements. For instance, according to Pharmaceutical Technology, in May 2024, Merck & Co. reported a research and development expenditure of $30.5 billion for the full year 2023, reflecting a broader industry trend toward capitalizing discovery infrastructures that rely on specialized instrumentation for precise molecular interaction analysis.

Concurrently, the Increasing Focus on Biologics and Personalized Medicine is reshaping the demand for label-free systems. Unlike small molecules, complex biologics such as monoclonal antibodies often exhibit altered binding behaviors when tagged with fluorescent markers, making label-free analysis indispensable for preserving native analyte conformation during screening. The rising commercial success of these large-molecule therapeutics fuels this demand; according to Purdue University, in May 2024, the US FDA approved 24 biologics in 2023, representing a substantial share of novel therapeutics entering the market. Furthermore, the global ecosystem is strengthened by public sector initiatives aimed at securing research capabilities. According to the UK Government, in October 2024, a £520 million Life Sciences Innovative Manufacturing Fund was launched to catalyze investment in the sector, fostering an environment conducive to the proliferation of advanced analytical technologies.

Market Challenge

The high initial capital expenditure required for label-free detection (LFD) instrumentation constitutes a substantial barrier to market expansion. These advanced analytical systems necessitate a significant upfront investment, which often renders them inaccessible to smaller academic laboratories and emerging biotechnology firms that operate with limited discretionary budgets. Unlike major pharmaceutical corporations, these smaller entities struggle to absorb such costs, forcing them to rely on traditional, less expensive labeling methods. This price sensitivity effectively excludes a large segment of the potential customer base, thereby limiting the technology's penetration into the broader life sciences community and concentrating usage primarily within well-funded institutions.

This financial impediment is further intensified by the tightening funding environment for the biotechnology sector. According to the 'Biotechnology Innovation Organization', in '2024', 'venture capital investment in early-stage therapeutic companies tracked at approximately $2.4 billion in the first quarter, reflecting a cautious funding environment for emerging enterprises'. When capital availability is restricted, startups are compelled to prioritize clinical development expenses over the acquisition of premium capital equipment. Consequently, the reduced purchasing power of these emerging firms directly suppresses the demand for LFD instrumentation, hampering the overall growth trajectory of the market.

Market Trends

The Integration of Artificial Intelligence and Machine Learning for Kinetic Analysis is fundamentally reshaping the interpretation of complex binding data in the label-free detection sector. As bioanalytical platforms generate increasingly voluminous datasets, manual processing has become a bottleneck, prompting the adoption of computational tools capable of deconvoluting intricate kinetic profiles in real-time. This digital transformation is driven by the necessity to improve the accuracy of binding affinity calculations and predict molecular behaviors earlier in the discovery pipeline. The industry's commitment to this technological shift is evident in recent capital allocations; according to the Pistoia Alliance, September 2025, in the 'Lab of the Future survey', artificial intelligence remained the primary investment priority for 63% of life science laboratories, underscoring a strategic pivot toward data-driven analytical frameworks that enhance the utility of label-free instrumentation.

Concurrently, the Shift Toward Automated and Robotic-Integrated Workflows is accelerating market growth by addressing the demand for higher throughput and reproducibility in drug screening. Laboratories are increasingly moving away from manual sample handling, which is prone to variability, favoring systems that support continuous, walk-away operation for large-scale campaigns. Manufacturers are responding with advanced instrumentation designed to integrate seamlessly into robotic ecosystems, thereby maximizing instrument utilization rates. For instance, according to Sartorius, May 2025, in the 'Octet R8e System' launch announcement, the platform's new evaporation control technology now enables unattended experimental run times of up to 16 hours, a capability that significantly extends operational windows for kinetic assays and facilitates the uninterrupted analysis required by modern high-throughput environments.

Key Market Players

• Ametek Inc
• Corning Incorporated
• Cytiva (Danaher Corporation)
• Horiba Ltd.
• Malvern Panalytical Ltd
• PerkinElmer Inc.
• Shimadzu Corporation
• Thermo Fisher Scientific

Report Scope

In this report, the Global Label-Free Detection (LFD) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Label-Free Detection (LFD) Market, By Product

• Consumables
• Instruments

Label-Free Detection (LFD) Market, By Technology

• Mass Spectrometry
• Surface Plasmon Resonance (SPR)
• Bio-Layer Interferometry
• Isothermal Titration Calorimetry
• Differential Scanning Calorimetry
• Other

Label-Free Detection (LFD) Market, By Application

• Binding Kinetics
• Binding Thermodynamics
• Endogenous Receptor Detection
• Hit Confirmation
• Lead Generation
• Other

Label-Free Detection (LFD) Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Label-Free Detection (LFD) Market.

Available Customizations:

Global Label-Free Detection (LFD) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Label-Free Detection (LFD) Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Instruments)
  • 5.2.2. By Technology (Mass Spectrometry, Surface Plasmon Resonance (SPR), Bio-Layer Interferometry, Isothermal Titration Calorimetry, Differential Scanning Calorimetry, Other)
  • 5.2.3. By Application (Binding Kinetics, Binding Thermodynamics, Endogenous Receptor Detection, Hit Confirmation, Lead Generation, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Label-Free Detection (LFD) Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Label-Free Detection (LFD) Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Label-Free Detection (LFD) Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Label-Free Detection (LFD) Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application

7. Europe Label-Free Detection (LFD) Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Label-Free Detection (LFD) Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
  • 7.3.2. France Label-Free Detection (LFD) Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Label-Free Detection (LFD) Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Label-Free Detection (LFD) Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Label-Free Detection (LFD) Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application

8. Asia Pacific Label-Free Detection (LFD) Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Label-Free Detection (LFD) Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
  • 8.3.2. India Label-Free Detection (LFD) Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Label-Free Detection (LFD) Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Label-Free Detection (LFD) Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Label-Free Detection (LFD) Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application

9. Middle East & Africa Label-Free Detection (LFD) Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Label-Free Detection (LFD) Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Label-Free Detection (LFD) Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Label-Free Detection (LFD) Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application

10. South America Label-Free Detection (LFD) Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Label-Free Detection (LFD) Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Label-Free Detection (LFD) Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Label-Free Detection (LFD) Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Label-Free Detection (LFD) Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Ametek Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Corning Incorporated
• 15.3. Cytiva (Danaher Corporation)
• 15.4. Horiba Ltd.
• 15.5. Malvern Panalytical Ltd
• 15.6. PerkinElmer Inc.
• 15.7. Shimadzu Corporation
• 15.8. Thermo Fisher Scientific

16. Strategic Recommendations

17. About Us & Disclaimer